Pharmaceutical Manufacturing of Vecuronium Bromide

The contract involves the manufacturing of Vecuronium Bromide for Injection, encompassing the full production lifecycle from chemical synthesis and purification to final formulation as a freeze-dried powder, all conducted in strict adherence to current Good Manufacturing Practices. The product must meet stringent quality and consistency standards required for pharmaceutical use, with packaging following military specifications to ensure stability, sterility, and readiness for deployment in field conditions. The manufacturing facility must be capable of handling controlled substances and maintaining compliance with both federal pharmaceutical regulations and Department of Defense supply chain requirements. The work is to be performed at Nellis Air Force Base, Nevada, with a 2026 submission deadline of August 10, and is classified as a subcontract under NAICS code 325412 for pharmaceutical preparation manufacturing. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating this product is intended for military medical use. All production activities must align with DoD logistics and procurement protocols, ensuring seamless integration into defense medical inventories and rapid deployment capability in operational environments.